Skip to content

Journey Medical Corporation DERM Business Segments — Revenue

Similar metrics at other companies

PBH
PBHDermatologicals — Total revenues
$30.49M+4.8%
Castle Biosciences logo
CSTLDermatologic — NET REVENUES
$41.11M-34.7%
Aclaris Therapeutics logo
ACRSDermatology Therapeutics — Revenue
$1.46M+44.5%
Zoetis logo
ZTSDermatology — Revenue
$349M-7.9%
Castle Biosciences logo
CSTLNon-Dermatologic — NET REVENUES
$42.57M+70.1%
Kiniksa Pharmaceuticals International, plc logo
KNSAPharmaceutical — Revenue
$214.27M+55.5%

Other financials

Income statement

See full
Revenue$16.0M+21.5%
Gross profit$9.7M+16.7%
Operating income-$1.5M+55.1%
Net income-$2.2M+45.2%
EPS (diluted)-$0.08+55.6%

Balance sheet

See full
Cash & equivalents$27.2M+29.2%
Total debt$25.5M+1.2%
Total equity$30.8M+43.1%
Total assets$91.5M+7.7%

Cash flow

See full
Operating cash flow$2.9M+203%
CapEx$3.8M
Free cash flow-$6.0M

Valuation

See full
Market cap$194.94M+20.9%
Enterprise value$193.19M+16.2%
P/S+0.2×

Profitability

See full
Gross margin65.4%-1.0pp
Operating margin-9.8%
Net margin-14.8%
FCF margin-43%

Returns & leverage

See full
Return on equity-36.6%
Debt / equity0.8×-0.3×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by Journey Medical Corporation in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's business segments — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Journey Medical Corporation's business segments — revenue?
Journey Medical Corporation (DERM) reported business segments — revenue of $15.96M in Q1 2026.
How has Journey Medical Corporation's business segments — revenue changed year-over-year?
Journey Medical Corporation's business segments — revenue increased by 21.5% year-over-year, from $13.14M to $15.96M.
What does business segments — revenue mean?
Represents the total gross income generated from the sale of dermatological pharmaceutical products and authorized generics. This metric serves as the primary indicator of market demand and commercial success for the company's skin-care portfolio.